Our results demonstrate the association between the novel GBA1 rs3115534 PD risk variant and an increased risk of RBD symptoms, and show that risk carriers are ~1.43 times more likely to have RBD symptoms than non-carriers. This evidence concerns the gene GBA1 and Parkinson disease.